To register for the webcast, click here . A replay will be available on the Corbus website.

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

MBX Biosciences, Inc. is rated a Buy, driven by canvuparatide's once-weekly dosing advantage in hypoparathyroidism. Learn ...

Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation ...

Global markets recovered quite well from the turmoil earlier this year. The S&P 500 Index has recently reached a new all-time high, and the MSCI Europe Index is close to doing so as well. The ...

Sotheby’s Collectors’ Week featured auctions, private sales, exhibitions and masterclasses hosted in collaboration with the ...

Operating Profit of $22 million, up 36.7% YoY, Operating Margin of 9.4%Double-digit growth in orders and salesEntering Second Half with $321 ...

IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels ...

Earnings call AeroVironment delivered record Q2 FY26 revenue of $472.5M, up 151% YoY (21% organic growth), and raised its FY26 revenue guidance floor to $1.95B. Bookings hit an all-time high of $1.4B, ...

The best business laptop in late 2025 is defined by its AI capabilities, military-grade durability, and stellar battery life, ...

In the January 2025 presentation, Jazz Pharmaceuticals expects zanidatamab to potentially receive approval and be launched as ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present data on potential treatments for pancreatic and gastric/gastroesophageal junction (G/GEJ) ...